1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$51.01 $-0.27 (-0.5%) 11 April 2026 at 5:58:57 am AEST

Moderna Chart and Price Data

About Moderna

Last updated 11-04-2026, 05:58:57am AEST
Current Price $51.01
Change $-0.27 (-0.5%)
Close Price $51.01
Open Price $51.56
Bid $50.99
Ask $51.02
Day Range $50.05 - $52.88
Year Range $22.28 - $59.55
Volume 177,867
Average Volume 10,425,760
Market Cap $20,126,091,400.00
Earnings Per Share $-7.26

    • Moderna (NASDAQ: MRNA)
    Latest News

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Market News

    Here are the 10 most traded ASX shares and US stocks in November

    | Bronwyn Allen

    A consumer staples share attracted the strongest buying conviction among investors using the Selfwealth platform last month.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    International Stock News

    Which stocks are most likely to thrive in a recession? Here's what history shows

    | Keith Speights

    Recession-proof stocks must offer something that makes investors want to buy them even when the economy is tanking.

    Read more »

    International Stock News

    1 bear market blunder investors are still making

    | David Jagielski

    Focusing on the short term could lead to long-term losses.

    Read more »

    A child covering his eyes hiding from a toy bear.
    International Stock News

    Prediction: This bear market will test your resolve in (at least) 3 ways

    | Alex Carchidi

    Your portfolio is counting on you to pass the tests.

    Read more »

    A man with a beard and wearing dark sunglasses and a beanie head covering raises a fist in happy celebration as he sits at is computer in a home environment.
    International Stock News

    5 tech stocks sending the Nasdaq higher on Wednesday

    | Jason Hall

    A combination of solid earnings and investor optimism has many of the year's losers seeing some gains.

    Read more »

    a man wearing spectacles has a satisfied look on his face as he appears within a graphic image of graphs, computer code and technology related symbols while he concentrates on a computer screen
    Technology Shares

    Why are ASX 200 tech shares having such a stellar run today?

    | Bernd Struben

    The NASDAQ 100 closed yesterday at its highest level since 4 May.

    Read more »

    A man at his desk in an office holds his hands up in the air in frustration while looking at the falling share price on his computer screen.
    International Stock News

    2 mistakes to avoid in a bear market

    | Prosper Junior Bakiny

    Falling for these traps could cost you money.

    Read more »

    woman preparing Moderna vaccine
    International Stock News

    3 things about Moderna that smart investors know

    | Jeff Santoro

    There's more to Moderna than its COVID-19 vaccines, which investors may not appreciate fully.

    Read more »

    A man leans forward propped on his elbows as he holds his clasped hands to his mouth in a worried pose as he gazes at his computer screen in a home setting.
    International Stock News

    Should you really buy stocks now or wait a while longer?

    | Adria Cimino

    Some stocks are trading at incredibly low prices.

    Read more »

    A doctor looks unsure.
    Share Market News

    Is Moderna listed on the ASX?

    | Sebastian Bowen

    Can ASX investors buy Moderna shares?

    Read more »

    A nurse administers a vaccine into the arm of a woman wearing a mask.
    International Stock News

    2 Nasdaq stocks bucking Monday's market drop

    | Dan Caplinger

    The Nasdaq Composite continued to lose ground, but these stocks held up.

    Read more »

    A man in a blue collared shirt sits at his desk doing a single fist pump as he watches the Appen share price rise on his laptop
    International Stock News

    This crypto could be the Moderna of 2022

    | Adria Cimino

    Like Moderna, it's young and dynamic.

    Read more »

    Profile

    since

    Note